Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Public ClinicalTrials.gov record NCT06772623. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Multi-Cohort Phase 1b/2 Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease and No Actionable Genomic Alterations
Study identification
- NCT ID
- NCT06772623
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 252 participants
Conditions and interventions
Conditions
Not listed
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 5, 2025
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2027
- Last update posted
- Feb 26, 2026
2025 – 2027
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Providence - St. Jude Medical Center /ID# 271414 | Fullerton | California | 92835 | Recruiting |
| FOMAT Medical Research - Clinica mi Salud by Focil Med /ID# 274450 | Oxnard | California | 93030 | Recruiting |
| UCLA - Santa Monica /ID# 271690 | Santa Monica | California | 90404 | Recruiting |
| University Of Colorado - Anschutz Medical Campus /ID# 269069 | Aurora | Colorado | 80045 | Recruiting |
| Rocky Mountain Cancer Centers - Lone Tree /ID# 272603 | Lone Tree | Colorado | 80124 | Recruiting |
| Mid Florida Hematology And Oncology Center /ID# 273777 | Orange City | Florida | 32763 | Recruiting |
| Hope And Healing Cancer Services /ID# 276223 | Hinsdale | Illinois | 60521 | Recruiting |
| Community Health Network /ID# 273437 | Indianapolis | Indiana | 46202 | Recruiting |
| Astera Cancer Care /ID# 271915 | East Brunswick | New Jersey | 08816-4096 | Recruiting |
| New York Cancer And Blood Specialists - Shirley /ID# 272547 | Shirley | New York | 11967 | Recruiting |
| University Hospitals Cleveland Medical Center /ID# 271726 | Cleveland | Ohio | 44106 | Recruiting |
| The Mark H Zangmeister Center /ID# 272502 | Columbus | Ohio | 43219 | Recruiting |
| Spoknwrd Clinical Trials /ID# 273776 | Easton | Pennsylvania | 18045 | Recruiting |
| Millennium Research & Clinical Development /ID# 271717 | Houston | Texas | 77090 | Completed |
| Joe Arrington Cancer Research /ID# 272776 | Lubbock | Texas | 79410-1121 | Recruiting |
| Huntsman Cancer Institute /ID# 271686 | Salt Lake City | Utah | 84112 | Recruiting |
| Virgnia Cancer Specialists /ID# 269633 | Leesburg | Virginia | 20176 | Recruiting |
| Vista Oncology - East Olympia /ID# 275438 | Olympia | Washington | 98506 | Recruiting |
| Northwest Medical Specialties Tacoma /ID# 270469 | Tacoma | Washington | 98405 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06772623, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06772623 live on ClinicalTrials.gov.